Sort   by:  
 Page size 
UnknownBetter resource utilisation and quality of care for ovarian cancer patients using internet-based pathology review.
Not available
S-EPMC5294479 | biostudies-literature
UnknownIncreased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study.
Not available
S-EPMC9814937 | biostudies-literature
UnknownMCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.
Not available
S-EPMC9035053 | biostudies-literature
UnknownGenome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease.
Not available
S-EPMC10915171 | biostudies-literature
UnknownDose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.
Not available
S-EPMC5744673 | biostudies-literature
UnknownCCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.
Not available
S-EPMC10107112 | biostudies-literature
UnknownClinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.
Not available
S-EPMC7463007 | biostudies-literature
UnknownGene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.
Not available
S-EPMC9751776 | biostudies-literature
Unknownp53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.
Not available
S-EPMC10073933 | biostudies-literature
UnknownBeyond <i>BRCA</i> deficiency: Clinical and molecular predictors of survival in patients with <i>BRCA</i>-deficient tubo-ovarian high-grade serous carcinoma.
Not available
S-EPMC12486008 | biostudies-literature
Sort   by:  
 Page size